ATWLPPR Peptide TFA
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-P1663A-1 mg |
| Pricing | 1 mg, USD $70.0 |
| Biological Activity | ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis[1]. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes[2]. |
| Purity | 98.99% |
| MWt | 954.0 |
| Formula | C₄₂H₆₂F₃N₁₁O₁₁ |